Share This Article:

Genetic and dietary factors related to schizophrenia

Abstract Full-Text HTML XML Download Download as PDF (Size:351KB) PP. 12-20
DOI: 10.4236/ojpsych.2012.21003    7,839 Downloads   13,431 Views   Citations

ABSTRACT

Biochemical, immunological and epidemiological evidence increasingly support the suggestion that there is a causal relationship between gluten/gliadin and schizophrenia as originally proposed by F. C. Dohan. Furthermore the necessary physiological mechanisms exist to explain a mechanism involving bioactive peptides from these proteins, and these show that this mechanism is possible and probable in at least in a substantial subgroup of schizophrenic patients. Evidence shows a fairly strong genetic disposition, and it must be recognised that any genetic mechanism must implicate altered chemistry and function of proteins. Evidence supports the likelihood that dietary intervention is beneficial for some, and this demands further investigation. A similar conclusion may apply to autism spectrum conditions.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Reichelt, K. and Gardner, M. (2012) Genetic and dietary factors related to schizophrenia. Open Journal of Psychiatry, 2, 12-20. doi: 10.4236/ojpsych.2012.21003.

References

[1] Kendler, K.S. and Diehl, S.R. (1993) The genetics of schizophrenia: A current genetic-epidemiologic perspective. Schizophrenia Bulletin, 19, 261-286.
[2] Gottesman, I.I. and Betelsen, A. (1989) Confusing unexpected phenotypes for schizophrenia. Risks in the off-spring of Fischer’s Danish identical and fraternal twins. Archives of General Psychiatry, 46, 867-872. doi:10.1001/archpsyc.1989.01810100009002
[3] Onstad, B., Skre, I., Torgersen, S. and Kringlen, E. (1991) Twin concordance for DSM-III-R Schizophrenia. Acta Psychiatrica Scandinavica, 83, 396-401. doi:10.1111/j.1600-0447.1991.tb05563.x
[4] Mednick, S.A., Schuolsinger, F., Higgins, J., Bell, B., Venables, P.H and Christiansen, K.O. (1974) Genetics, environment and psychpathology. Elsevier, North Holland Press, New York.
[5] Frohman C.E., Czaijkowski, N., Luby, E.D., Gottlieb, J.B. and Senf, R. (1960) Further evidence of a plasma factor in schizophrenia. Archives of General Psychiatry, 2, 263-267. doi:10.1001/archpsyc.1960.03590090011003
[6] Berger, J.R., Gray, F.W. and Punnell, R.B. (1965) Tarexein-like extracts: Effects on rat behavior. Archives of General Psychiatry, 22, 80-82. doi:10.1001/archpsyc.1965.01720310082011
[7] Heath, R.G., Martens, S., Leacvh, B.E., Cohen, M. and Angel, C. (1957) Effect on behaviour in humans with the administration of tarexein. American Journal of Psychiatry, 114, 14-24.
[8] Vojdani, A., Pangborn, J.B., Vojdani, E. and Cooper, E.L. (2003) Infections, toxic chemicals and dietary peptides binding to lymphocytes receptors and tissue enzymes are major instigators of autoimmunity in autism. International Journal of Immunopathology and Pharmacology, 16, 189-199.
[9] Reichelt K.L. (2007) Low molecular weight peptides. In: Lajhta, A., Oja, S.S., Schousboe, A and Saransaari, P. Eds., Handbook of Neurochemistry and Molecular Neurobiology. (Amino acids and peptides in the nervous system), Springer, New York, 402-411. doi:10.1007/978-0-387-30373-4_16
[10] Wada, J. and Gibson, W.C. (1959) Behavioral and EEG changes induced by injection of schizophrenic urine extracts. Archives of Neurology and Psychiatry, 81, 747-764.
[11] Hole, K., Bergslien, A.A., J?rgensen, H., Berge, O.-G., Reichelt, K.L. and Trygstad, O.E. (1979) A peptide-containing fraction from schizophrenia which stimulates opiate receptors and inhibits dopamine uptake. Neuroscience, 4, 1139-1147. doi:10.1016/0306-4522(79)90062-9
[12] Reichelt, K. Ll Hole, K., Hamberger, A., Saelid, G., Edminson, P.D., Braestsrup, C.I., et al. (1981) Biologically active peptide-containing fractions in schizophrenia and childhood autism. Advances in Biochemical Psychopharmacology, 28, 627-649.
[13] Drysdale, A., Deacon, R., Lewis, P., Olly, J., Electricwala, A. and Sherwood, R. (1982) A peptide containing fraction of plasma of schizophrenic patients which binds to opiate receptors and induces hyperactivity in rats. Neuroscience, 7, 1567-1574. doi:10.1016/0306-4522(82)90265-2
[14] Idet, M., Grof, J., Menyhart,J. and Pajor, A. (1982) Elevated opioid activity in sera of chronic schizophrenia. Acta Physiologica Hungarica, 60, 121-127.
[15] Lindstrom, L.H., Besev, G., Gunne, L.M., Terenius, L. (1986) CSF levels of receptor-active endorphins in schizophrenic patients: Correlation with symptomatology and monoamine metabolites. Psychiatry Research, 19, 93-100. doi:10.1016/0165-1781(86)90001-6
[16] Cade, R., Privette, M., Fregly, M., Rowland, N., Sun, Z., Zele,V., et al. (2000) Autism and schizophrenia: Intestinal disorders. Nutritional Neuroscience, 3, 57-72.
[17] Dohan, F.C., Levitt, D.R. and Hushnir, L.D. (1978) Abnormal behaviour after intracerebral injection of polypeptides from wheat gliadin. Pakistan Journal of Biological Sciences, 13, 73-82.
[18] Reichelt, W.H., Stensrud, M.B. and Reichelt, K.L. (1998) Peptide excretion in celiac disease. Journal of Pediatric Gastroenterology and Nutrition, 26, 305-309. doi:10.1097/00005176-199803000-00012
[19] Liu, Y., Heiberg, T. and Reichelt, K.L. (2007) Towards a possible aetiology for depressions? Behavioral and Brain Functions, 3, 47-53. doi:10.1186/1744-9081-3-47
[20] Zioudrou, C., Streaty, R.A. and Klee, W.A. (1979) Opioid peptides derived from food proteins. The exorphins. The Journal of Biological Chemistry, 254, 2446-2449.
[21] Gardner, M.L.G. (1994) Absorption of intact proteins and peptides. In: Johnson, L.R. Ed., Physiology of the Gastrointestinal Tract, 3rd Edition, Raven Press, New York, pp. 1791-1820.
[22] Fukudome, S. and Yoshikawa, M. (1992) Opioid peptides derived from what gluten: Their isolation and characterisation. FEBS Letters, 296, 107-111. doi:10.1016/0014-5793(92)80414-C
[23] Fukudome, S. and Yoshikawa, M. (1993) A novel opioid peptides derived from what gluten. FEBS Letters, 316, 17-19. doi:10.1016/0014-5793(93)81727-H
[24] Gardner, M.L.G. (1985) Production of pharmacologically active peptides from foods and the gut. In: Hunter, J.O. and Jones, V.A. Eds., Food and the Gut. Bailliere Tindall, London, 121-134.
[25] Brantl, V., Teschemacher, H., Henschen, A. and Lottspeich, F. (1979) Novel opioid peptides derived from casein (β-casomorphins). Isolation from bovine casein peptone. Hoppe-Seyler’s Zeitschrift fur physiologische Chemie, 360, 1211-1216. doi:10.1515/bchm2.1979.360.2.1211
[26] Sun, Z. and Cade, J.R. (1999) A peptide found in schizophrenia and autism causes behavioural changes in rats. Autism, 3, 85-95. doi:10.1177/1362361399003001007
[27] Sun, Z., Cade, R.J., Fregly, M.J. and Privette, R.M. (1999) Beta-casomorphine induces Fos-like immunoreactivity in discrete brain regions relevant to schizophrenia and autism. Autism, 3, 67-83. doi:10.1177/1362361399003001006
[28] Lindstrom, L.H., Nyberg, F., Terenius, L., Bauer, K., Besev, G., Lyrenas, L.M., et al. (1984). CSF and Plasma beta-casomorphin-like opioid peptides in postpartum psychosis. The American Journal of Psychiatry, 141, 1050-1066.
[29] Reichelt, K.L. and Landmark, J. (1995) Specific IgA antibody increases in schizophrenia. Biological Psychiatry, 37, 410-413. doi:10.1016/0006-3223(94)00176-4
[30] Samaroo, D., Dickerson, F., Kasarda, D.D., Green, P.H.R., Briani, C., Yolken, R.H., et al. (2010). Novel immune response to gluten in individuals with schizophrenia. Schizophrenia Research, 118, 248-255. doi:10.1016/j.schres.2009.08.009
[31] Dickerson, F., Stallings, C., Origoni, A., Vaughan, C., Khushalani, S., Leister, F., et al. (2010) Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biological Psychiatry, 58, 100-104. doi:10.1016/j.biopsych.2010.03.021
[32] Cascella, N.G., Kryszak, D., Bhatti, B., Gregory, P., Kelly, D.L., McEvoy, J.P., et al. (2011) Prevalence of celiac disease and gluten sensitivity in the United States. Clinical Antipsychotic trials of intervention, Effectiveness study Population. Schizophrenia Bulletin, 37, 94-100. doi:10.1093/schbul/sbp055
[33] Jin, S., Wu, N., Xu, Q., Zhang, X., Ju, G.-Z., Law, M.H. and Wei, J. (2011) A study of cocirculating gliadin anti-bodies in schizophrenia among Chinese population. Schizophrenia Bulletin, 37, 748-752.
[34] Niebuhr, D.W., Li, Y., Cowan, D.N., Weber, N.S., Fisher, J.A., Ford, G.M. and Yolken, R. (2011) Association of bovine casein antibody and new onset schizophrenia among US military personnel. Schizophrenia Research, 128, 51-55. doi:10.1016/j.schres.2011.02.005
[35] Severance, E.G., Dickerson, F.B., Halling, M., Krivogorsky, B., Haile, L., Yang, S., et al. (2010) Subunit and whole molecule specificity of anti-bovine casein immune response in recent onset psychosis and schizophrenia. Schizophrenia Research, 118, 240-247.
[36] Gupta, S., Masand, P.S., Kaplan, D., Dhandadary, A. and Hendricks, S. (1997) The relationship between schizophrenia and irritable bowel syndrome (IBS). Schizophrenia Research, 23, 265-268. doi:10.1016/S0920-9964(96)00099-0
[37] Eaton, W.W., Mortensen, P.B., Agerbo, E., Byrne, M., Mors, O. and Ewald, H. (2004). Coeliac disease and schizophrenia: Population based case control study with linkage of Danish national registers. British Medical Journal, 328, 438-439. doi:10.1136/bmj.328.7437.438
[38] Kalaydjian, A.E., Eaton, W., Cascella, N. and Fasano, A. (2005). The gluten connection: The association between schizophrenia and celiac disease. Acta Psychiatrica Scandinavica, 113, 82-89. doi:10.1111/j.1600-0447.2005.00687.x
[39] Vojdani, A., O’Brian, T., Green, J.A., McCandless, J., Woeller, K.N., Vojdani, E., et al. (2004) Immune response to dietary protein gliadin and cerebellar peptides in children with autism. Nature Neuroscience, 7, 151-161. doi:10.1080/10284150400004155
[40] Dohan, F.C. (1966) Cereals and schizophrenia. Data and hypothesis. Acta Psychiatrica Scandinavica, 42, 125-152. doi:10.1111/j.1600-0447.1966.tb01920.x
[41] Dohan, F.C., Martin, L., Grasberger, J.C., Boehme, D. and Cotrell, J.C. (1972) Antibodies to wheat gliadin in blood of psychiatric patients. Possible role of emotional factors. Biological Psychiatry, 5, 127-131.
[42] Reichelt, K.L., Seim, A.R. and Reichelt, W.H. (1996) Could schizophrenia be reasonably explained by Dohan’s hypothesis on genetic interaction with a dietary peptide overload? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 20, 1083-1114. doi:10.1016/S0278-5846(96)00099-1
[43] Dohan, F.C., Harper, E.M., Clark, M.H., Rodrigue, R.B. and Zigas, V. (1984) Is schizophrenia rare if grain is rare? Biological Psychiatry, 19, 385-399.
[44] Dohan, F.C. and Graasberger, J.C. (1973) Relapsed schizophrenics: Earlier discharge from the hospital after cereal-free, milk-free diet. American Journal of Psychiatry, 30, 685-686.
[45] Singh, M.M. and Kay, S.R. (1976) Wheat gluten as a pathogenic factor in schizophrenia. Science, 181, 401-402. doi:10.1126/science.1246624
[46] Reichelt, K.L., Sagedal, E., Landmark, J., Sangvik, B.T., Eggen, O. And Scott, H. (1990) The effect of gluten-free diet on urinary peptide excretion and clinical state in schizophrenia. The Journal of Orthomolecular Medicine, 5, 223-239.
[47] Madsen, A.L., Karle, A., Rubin, P., Cortsen, M., Andersen and H.S., Hemmingsen, R. (1991) Progressive atrophy of the frontal lobes in first episode schizophrenia: Interaction with clinical curse and neuroleptic treatment. Acta Psychiatrica Scandinavica, 100, 367-374. doi:10.1111/j.1600-0447.1999.tb10880.x
[48] Rice, J.R., Ham, C.M. and Gore, W.E. (1978) Another look at gluten in schizophrenia. American Journal of Psychiatry, 135, 1147-1148.
[49] Potkin, S.G., Weinberger, D., Kleiman, J., Nasrallah, H., Luchins, D. and Bigelow, I. (1981) Wheat gluten challange in schizophrenic patients. American Journal of Psychiatry, 138, 1208-1211.
[50] Storms, L.H., Clopton, J.M. and Wright, C. (1982) Effects of gluten in schizophrenics. Archives of General Psychiatry, 39, 323-327. doi:10.1001/archpsyc.1982.04290030055010
[51] Vlissides, D.N., Venulet, A. and Jenner, F.A. (1986) A double blind gluten-free gluten load controlled trial in a secure ward population. The British Journal of Psychiatry, 148, 447-452. doi:10.1192/bjp.148.4.447
[52] Jansson, N., Kristjansson, E., Nilsson, L., et al. (1984) Schizophren psykosbild avklingade nar pasientengavs gluen fri kost. Lakartidningen, 81, 148-149.
[53] Graff, K. and Handford, A. (1961) Celiac syndrome in the case histories of five schizophrenics. Psychology Quarter, 35, 306-313. doi:10.1007/BF01566581
[54] De Santis, A., Addolorato, A., Romito, S., Caputo, A., Giordano, G., Gambassi, C., et al. (1997) Schizophrenia symptoms and spectrum abnormalities in a coeliac patient: Regression after a gluten-free diet. Journal of Internal Medicine, 242, 421-423. doi:10.1046/j.1365-2796.1997.00200.x
[55] Abassi, Z., Golomb, E. and Keiser, H.R. (1992) Neutral endopeptidase inhibition increases urinary excretion and plasma level of endothelin. Metabolism, 41, 683-685. doi:10.1016/0026-0495(92)90303-R
[56] Watanabe,Y., Kojima-Kumatsu, T., Iwaki-Egewa, S., Fujimoto, Y. (1993) Increased excretion of proline-containing peptides in dipeptidyl peptidase IV deficient rats. Research Communications in Chemical Pathology & Pharmacology, 81, 323-350.
[57] Cantor-Graae, E. and Selten, P (2005) Schizophrenia and migration: A meta-analysis and review. American Journal of Psychiatry, 16, 12-24. doi:10.1176/appi.ajp.162.1.12
[58] Hadjivassiliou, M., Boscolo, S., Davies-Jones, G.A.B., Grunewald, R.A., Not, T., Sanders, D.S., .et al. (2002) The humoral response in the pathogenesis of gluten ataxia. Neurology, 58, 1221-1226.
[59] Zagon, I.S. and McLaughlin, P.J. (1987) Endogenous opioid systems regulate cell proliferation in the developing rat brain. Brain Research, 412, 68-72. doi:10.1016/0006-8993(87)91440-5
[60] Hauser, K.F., McLaughlin, P.I. and Zagon, I.S. (1989) Endogenous opioid systems and the regulation of dendritic growth and spine formation. The Journal of Comparative Neurology, 281, 13-22. doi:10.1002/cne.902810103
[61] Svedberg, J., De Haas, J., Leimanstoll, G., Paul, F., Teschemacher, H. (1985) Demonstration of beta-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestinal contents after bovine milk ingestion in adult humans. Peptides, 6, 825-831. doi:10.1016/0196-9781(85)90308-0
[62] Chabance, B., Marteau, P., Rambaud, J.C., Migliore-Samour, D., Boynard, M., Perrotin, P., et al. (1998) Casein peptides release and passage to the blood in humans during digestion of milk and yogurt. Biochimie, 80, 155-165. doi:10.1016/S0300-9084(98)80022-9
[63] Matthews, D.M. (1991) Protein Absorption: Development and Present State of the Subject. Wiley-Liss, New York.
[64] Gardner, M.L.G. (1994) Absorption of intact proteins and peptides. In: Johnson, L.R. Ed. Physiology of the Gastro-intestinal Tract, Raven Press, New York, 1795-1820.
[65] D'Eufemia, P., Celli, M., Finocchiaro, R. Pacifico, L., Viozzi, L., Zaccagnini, M., et al. ( 1996) Abnormal intestinal permeability in children with autism. Acta Paediatrica, 85, 1076-1079. doi:10.1111/j.1651-2227.1996.tb14220.x
[66] Lambert, M.T., Bjarnasson, I., Connelly, J., et al. (1989) Small intestine permeability in schizophrenia. The British Journal of Psychiatry, 155, 619-622.
[67] Wood, N.C., Hamilton, I., Axon, A.T.R., et al. (1987). Abnormal intestinal permeability. An aetiological factor in chronic psychiatric disorders? The British Journal of Psychiatry, 150, 853-856. doi:10.1192/bjp.150.6.853
[68] de Magistris, L., Familiari, V., Pascono, A., Sapone, A., Frolli, A., Iardino, P., et al. (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. Journal of Pediatric Gastroenterology and Nutrition, 51, 418-424.
[69] Jyonouchi, H., Sun, S. and Itokazu, N. (2002) Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology, 46, 76-84. doi:10.1159/000065416
[70] Bouras, M., Huneau, J.F. and Tome, D. (1996). The inhibition of intestinal dipeptidylaminopeptidase-IV promotes the absorption of enterostatin and des-arginine-enterostatin across rat jejunum in vitro. Life Sciences, 59, 2147-2155. doi:10.1016/S0024-3205(96)00571-1
[71] Foltz, M., Meynen, E.E., Bianco, V., van Palterink, C., Koning, T.M., Kloek, J. (2007) Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. Journal of Nutrition, 137, 953-958.
[72] Husby, S., Jensenius, J.C. and Cant, A.J. (1984) Passage of undegraded dietary antigen into the blood of healthy adults. Scandinavian Journal of Immunology, 22, 83-92. doi:10.1111/j.1365-3083.1985.tb01862.x
[73] Kilshaw, P.J. and Cant, A.J. (1984) The passage of maternal dietary protein into human breast milk. Inter- national Archives of Allergy and Immunology, 75, 8-15. doi:10.1159/000233582
[74] Langer S.Z. (1997) 25 years since the discovery of presynaptic receptors: Present knowledge and future perspectives. Trends in Pharmacological Sciences, 18, 95-99. doi:10.1016/S0165-6147(96)01034-6
[75] Gardner, M.L.G. and Steffens, K.-J. (1995) Absorption of Orally Administered Enzymes. Springer Verlag, Berlin, Heidelberg, New York.
[76] Ermisch, A., Brust, P., Kretzchmar, R., Buhle, H.-J. (1983) On the blood-brain barrier to peptides. (3H) beta-casomorphin-5 uptake by eighteen brain regions in vivo. Journal of Neurochemistry, 41, 1229-1233. doi:10.1111/j.1471-4159.1983.tb00816.x
[77] Nyberg, F., Liberman, R., Lindstrom, L.H., Lyrenas, S., Koch, G. and Terenius, L. (1989) Immunoreactive beta-casomorphin-8 in cerebrospinal fluid from pregnant and lactating women: Correlation with plasma level. The Journal of Clinical Endocrinology & Metabolism, 68, 283- 289. doi:10.1210/jcem-68-2-283
[78] Bauer, K. and Kornhuber, J. (1987) Blood brain barrier in schizophrenic patients. European Archives of Psychiatry & Neurological Sciences, 236, 257-259. doi:10.1007/BF00380949
[79] Kirch, D.G., Alexander, R.C., Suddath N.R.I., Papadopoulos, N.M., Kaufmann, C.A., Wyatt, D. and Wyatt, R.J. (1992) Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia. Journal of Neural Transmission, 89, 219-232. doi:10.1007/BF01250674
[80] Paul, K.-D., Henker, J., Todt, A., Eysold, R. (1985) EEG-Befunde zoeliakikranken kindern in abh?ngigkeit von der ernahrung. Zeitschrift fur klinische Medizin, 40, 707-709.
[81] Uhlig, T., Merkenschlager, A., Brandmaier, R. and Egger J. (1997) Topographic mapping of brain electrical activity in children with food-induced attention deficit hyperactivity disorder. European Journal of Pediatrics, 156, 557-561. doi:10.1007/s004310050662
[82] Geissler, A., Andus, T., Roth, M., Kullman, F., Caesar, L., Held, P., et al. (1996) Focal white matter lesions in brain of patients with inflammatory bowel disease. Lancet, 345, 89-90.
[83] Hart, P.E., Gould, S.R., MacSweeney, J.E., Clifton, A. and Schon, F. (1998) Brain white matter lesions in inflammatory bowel disease. Lancet, 351, 1558. doi:10.1016/S0140-6736(05)61123-3
[84] Heyman, M. and Desjeux, J.F. (2000) Cytokine-induced alteration of epithelial barrier to food antigens in disease. Annals of the New York Academy of Sciences, 915, 304-311. doi:10.1111/j.1749-6632.2000.tb05258.x
[85] Alander, T., Svardsudd, K., Johansson, S.E. and Agreus, L. (2005) Psychological illness is commonly associated with functional gastrointestinal disorders and important to consider during patient consultation: A population-based study. BMC Medicine, 3, 8-20. doi:10.1186/1741-7015-3-8
[86] Haug, T.T., Mykletun, A. and Dahl, A.A. (2005) Are anxiety and depression related to gastrointestinal symptoms in the general population? Scandinavian Journal of Gastroenterology, 37, 294-298. doi:10.1080/003655202317284192
[87] Pynnonen, P.A., Isometsa, E.T., Verkesalo, M.A., Kahkonen, S.A., Sipila, I., et al. (2005) Gluten-free diet may alleviate depressive and behavioural symptoms in adolescents with coeliac disease: A prospective follow-up case-series study. BMC Psychiatry, 8, 14-19.
[88] Reiter, P.J. (1926) Extrrapyramidal motor-disturbances in Dementia Praecox. Acta Psychiatrica et Neurologica Scandinavica, 1, 287-310. doi:10.1111/j.1600-0447.1926.tb11031.x
[89] Hemmings, G.P. (2004) Schizophrenia. Lancet, 364, 1312-1313. doi:10.1016/S0140-6736(04)17181-X

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.